Articles

Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment

Record identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326979

Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326979

Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment

Full title

Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Immunogenetics (New York), 2019, Vol.71 (2), p.71-86

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326979

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

SCOPE AND CONTENTS

Contents

Adoptive cell transfer (ACT) is a form of personalised immunotherapy which has shown promising results in metastasised cancer. For this treatment, autologous T lymphocytes are selected and stimulated in vitro before re-administration in large numbers. However, only a fraction of patients benefit from ACT, and it is not yet known what biomarkers can...

ALTERNATIVE TITLES

Full title

Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326979

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326979

OTHER IDENTIFIERS

ISSN

0093-7711

E-ISSN

1432-1211

DOI

10.1007/s00251-018-1083-1

How to access this item

Online

1 item

How to access?

Login with a Library card